EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 7,310.00
-100.00 (-1.35%)
Apr 10, 2026, 3:30 PM KST
EASY BIO,Inc. Revenue
In the year 2025, EASY BIO,Inc. had annual revenue of 476.94B KRW with 24.10% growth. EASY BIO,Inc. had revenue of 129.32B in the quarter ending December 31, 2025, with 9.94% growth.
Revenue
476.94B
Revenue Growth
+24.10%
P/S Ratio
0.51
Revenue / Employee
3.61B
Employees
132
Market Cap
241.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 476.94B | 92.61B | 24.10% |
| Dec 31, 2024 | 384.33B | 218.95B | 132.39% |
| Dec 31, 2023 | 165.39B | 9.83B | 6.32% |
| Dec 31, 2022 | 155.56B | 26.10B | 20.16% |
| Dec 31, 2021 | 129.46B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bioneer | 330.11B |
| Macrogen | 195.27B |
| BINEX | 168.47B |
| GC Cell | 165.52B |
| JETEMA, | 76.90B |
| HLB Therapeutics | 69.56B |
| Anterogen.Co.,Ltd. | 7.54B |
| Genexine | 5.81B |